The post Lighter drops 14% after losing $2 support – More pain ahead for LIT? appeared on BitcoinEthereumNews.com. Since it touched a high of $4.5, Lighter has The post Lighter drops 14% after losing $2 support – More pain ahead for LIT? appeared on BitcoinEthereumNews.com. Since it touched a high of $4.5, Lighter has

Lighter drops 14% after losing $2 support – More pain ahead for LIT?

Since it touched a high of $4.5, Lighter has experienced massive downside pressure. A week ago, the altcoin attempted an upside movement but was met with a sharp rejection at $3.2. 

As a result, the altcoin’s downside pressure intensified, breaching the $2 support level. As of this writing, Lighter [LIT] traded at $1.86, down 14.31% on daily charts, extending a week-long bearish pressure.

Lighter debuts staking of LIT 

Despite prevailing market conditions, Lighter expanded its market reach by launching staking for LIT on Lighter.

According to the team, users who have staked LIT will have access to the Lighter Liquidity Pool (LLP). Also, for every 1 LIT staked, 10 USDC will be deposited into the LLP.

Thus, the ecosystem will see improvements in the gap between LIT and LLP holders, thereby effectively adjusting risk-adjusted returns.

Most importantly, staking LIT on Lighter will earn yield, thereby incentivizing market players to continue staking.

Interestingly, just a few hours after staking went live, the demand for the services surged significantly. According to Oxjermo, after staking went live on Lighter, the amount staked jumped to 10% of the total circulating supply.

Coupled with that, analysts have experienced different opinions following the launch. One such analyst was Thor, who posited that LIT staking will be a bullish addition, as revenue will rise as MMS pays higher trading fees.

At the same time, the analyst noted that staking could put higher bearish pressure on LIT. This could be the case with TVL facing increased outflows as holders seek to withdraw and buy LIT.

Despite the launch, the market’s bearish trend has continued, as LLP holders withdrew to purchase LIT tokens.

Lighter whale sits on $2.84 million unrealized loss

As Lighter downside momentum persisted, LIT dropped below $2, and whales’ futures losses rose significantly. 

According to Onchain Lens, a whale holding a LIT (3x) long position is now having a floating loss of over $2.84 million.

If the whale chooses to sell at the current rate, he will take losses, and if he continues to hold, a forced liquidation could come his way. 

Source: Onchain lens

Another whale also faced the same fate. This whale partially liquidated its LIT (1x) long position, resulting in a $509K loss, according to Onchain Lens.

Despite the rising liquidation threat, this whale still holds the position with the next liquidation price of $1.49. 

Source: CoinGlass

Interestingly, these two whales are not isolated cases, as liquidations, especially for longs, have surged significantly. 

On January 15, Lighter saw $2.17 million in long positions liquidated, bringing the total liquidated to $8.7 million. 

Is LIT on the verge of more losses?

Lighter fell on its price charts as investors across the markets panicked and closed positions after a drop below $2.

As a result, the downward momentum strengthened even further. In fact, its Stochastic RSI fell further into the oversold zone, sitting at 2.3 as of this writing.

At the same time, the altcoins’ Relative Strength Index (RSI) dropped to 44, after making a bearish crossover days ago.

Source: TradingView

With these momentum indicators deep in the bearish zone, they suggested seller dominance and heightened downside momentum.

Therefore, if sellers continue to dominate, LIT is likely to drop further towards $1.5. Conversely, if demand for LIT rebounds, driven by the staking series, it could push it back towards $2.6.


Final Thoughts

  • A Lighter whale holding a LIT (3x) long position now sits on unrealized loss of over $2.84 million. 
  • LIT staked on Lighter reached a record-breaking 10% of the circulating supply hours after staking went live.
Previous: Crypto card payments overtake P2P stablecoin transfers: Artemis report
Next: U.S. Senate delays crypto market structure bill after Coinbase raises objections

Source: https://ambcrypto.com/lighter-whale-unrealized-losses-hit-2-8mln-is-lit-at-risk-of-further-dip/

Piyasa Fırsatı
Lighter Logosu
Lighter Fiyatı(LIT)
$1.873
$1.873$1.873
-3.05%
USD
Lighter (LIT) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Paylaş
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Paylaş
BitcoinEthereumNews2025/09/18 01:23